GPR42: A Potential Drug Target and Biomarker (G2866)

Target Name: GPR42

NCBI ID: G2866

GPR42

GPR42: A Potential Drug Target and Biomarker

G-protein coupled receptors (GPCRs) are a family of transmembrane proteins that play a crucial role in cellular signaling. These receptors are involved in various physiological processes, including sensory perception, neurotransmission, and hormone signaling. GPCRs have become a focus of intense research due to their potential as drug targets and biomarkers. In this article, we will discuss GPR42, a GPCR that has emerged as a promising drug target and biomarker.

GPR42: Structure and Function

GPR42 is a 7-transmembrane protein that consists of an extracellular loop, a transmembrane segment, and an intracellular loop. It has a unique molecular architecture, as it contains a split transmembrane region and an intracellular segment. The split transmembrane region consists of a catalytic 伪-helices that are involved in the GPCR signaling pathway. The transmembrane segment houses the extracellular portion of the protein and is involved in the formation of the receptor complex. The intracellular loop is a short, cytoplasmic region that plays a critical role in the regulation of GPCR signaling.

GPR42 is a GPCR that is expressed in various tissues, including the brain, eye, and heart. It is involved in the regulation of neural and cardiovascular signaling pathways. GPR42 has been shown to play a role in the regulation of pain perception, anxiety, and depression. GPR42 has also been implicated in the regulation of neurotransmitter release and neurotransmission.

Drug Targeting and Biomarker Potential

GPR42 has emerged as a promising drug target due to its unique molecular architecture and its involvement in various physiological processes. One of the main advantages of GPR42 as a drug target is its high degree of druggability. The split transmembrane region provides a potential target for small molecules, making it an attractive candidate for drug development. Additionally, the intracellular loop provides a potential target for agents that can modulate intracellular signaling pathways.

GPR42 has also been shown to be a potential biomarker for various psychiatric and neurological disorders. The regulation of GPR42 by small molecules has been shown to contribute to the pathophysiology of psychiatric and neurological disorders. GPR42 has been shown to play a role in the regulation of neurotransmitter release and neurotransmission, making it an attractive candidate as a biomarker for various psychiatric and neurological disorders.

Conclusion

GPR42 is a unique GPCR that has emerged as a promising drug target and biomarker. Its unique molecular architecture and its involvement in various physiological processes make it an attractive candidate for drug development. Additionally, GPR42 has been shown to play a role in the regulation of neurotransmission and neurotransmission, making it an attractive candidate as a biomarker for various psychiatric and neurological disorders. Further research is needed to fully understand the role of GPR42 in cellular signaling and its potential as a drug target and biomarker.

Protein Name: G Protein-coupled Receptor 42

Functions: Probable G protein-coupled receptor that may be activated by a major product of dietary fiber digestion, the short chain fatty acids (SCFAs), and that may play a role in the regulation of whole-body energy homeostasis and/or in intestinal immunity

The "GPR42 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPR42 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets